Thr399Ile Polymorphism of Toll-Like Receptor 4 Gene and COVID -19 Severity in Samples of Iraqi Patients: Baghdad Province
Iraqi Journal of Medical Sciences · 01.12.2025 · 23 (2)
DOI: 10.22578/ijms.23.2.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 01.12.2025. Verfasst von Marwa F. Jaber und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Toll-like receptor 4 (TLR4) is a pattern recognition receptor involved in the innate immune response, capable of recognizing certain molecular patterns found in bacteria and viruses, including the severe acute respiratory syndrome coronavirus 2 (SARS–CoV2) virus responsible for Corona virus disease 2019 (COVID-19).
Objective
To investigate the potential relationship between the severity of COVID-19 and a specific genetic variation in the TLR4 gene known as Thr399Ile.
Methods
A cross-sectional study conducted on 90 patients with COVID-19 in Baghdad. The researchers genotyping of Thr399Ile polymorphism in DNA extracted from blood samples of patients was done using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analyses.
Results
Two genotypes were found CC and CT, and no patients exhibiting the TT genotype. The CC genotype was associated with a DNA fragment size of 407 base pairs, while the CT genotype showed a size of 378 + 29 base pairs. In the non-severe infection group, the CC genotype frequency was 95.55%, while the CT genotype frequency was 4.44%. In the severe infection group, the CC genotype frequency was 93.33%, and the CT genotype frequency was 6.66%. This indicates no significant association between Thr399Ile polymorphism and COVID-19 severity. Thr399Ile mutant allele frequency among the 90 COVID-19 patients was found to be 5.5% (5 out of 90).
Conclusion
Functionally effective Thr399Ile polymorphism of TLR4 gene have apparently no influence on the individual susceptibility for COVID-19 severity infection.Keywords: COVID-19, TLR4, Thr399Ile polymorphism, mutant allele frequency.Citation: Jaber MF, Khudhair AM. Thr399Ile Polymorphism of toll-like receptor 4 gene and COVID -19 severity in samples of Iraqi patients: Baghdad province. Iraqi JMS. 2025; 23(2): 264-271. doi: 10.22578/IJMS.23.2.9
Zitieren
APA
Jaber, M. F., & Khudhair, A. M. (2025). Thr399Ile Polymorphism of Toll-Like Receptor 4 Gene and COVID -19 Severity in Samples of Iraqi Patients: Baghdad Province. Iraqi Journal of Medical Sciences, 23(2). https://doi.org/10.22578/ijms.23.2.9
Vancouver
Jaber MF, Khudhair AM. Thr399Ile Polymorphism of Toll-Like Receptor 4 Gene and COVID -19 Severity in Samples of Iraqi Patients: Baghdad Province. Iraqi Journal of Medical Sciences. 2025;23(2). doi:10.22578/ijms.23.2.9
BibTeX
@article{Jaber2025,
author = {Jaber, Marwa F. and Khudhair, Anfal M.},
title = {Thr399Ile Polymorphism of Toll-Like Receptor 4 Gene and COVID -19 Severity in Samples of Iraqi Patients: Baghdad Province},
journal = {Iraqi Journal of Medical Sciences},
year = {2025},
volume = {23},
number = {2},
doi = {10.22578/ijms.23.2.9}
}
EUVIMED